Abnormal_JJ
NF-kappa_NN
B_NN
activity_NN
in_IN
T_NN
lymphocytes_NNS
from_IN
patients_NNS
with_IN
systemic_JJ
lupus_NN
erythematosus_NN
is_VBZ
associated_VBN
with_IN
decreased_VBN
p65-RelA_NN
protein_NN
expression_NN
._.

Numerous_JJ
cellular_JJ
and_CC
biochemical_JJ
abnormalities_NNS
in_IN
immune_JJ
regulation_NN
have_VBP
been_VBN
described_VBN
in_IN
patients_NNS
with_IN
systemic_JJ
lupus_NN
erythematosus_NN
-LRB-_-LRB-
SLE_NN
-RRB-_-RRB-
,_,
including_VBG
surface_NN
Ag_NN
receptor-initiated_JJ
signaling_NN
events_NNS
and_CC
lymphokine_NN
production_NN
._.

Because_IN
NF-kappa_NN
B_NN
contributes_VBZ
to_TO
the_DT
transcription_NN
of_IN
numerous_JJ
inflammatory_JJ
genes_NNS
and_CC
has_VBZ
been_VBN
shown_VBN
to_TO
be_VB
a_DT
molecular_JJ
target_NN
of_IN
antiinflammatory_JJ
drugs_NNS
,_,
we_PRP
sought_VBD
to_TO
characterize_VB
the_DT
functional_JJ
role_NN
of_IN
the_DT
NF-kappa_NN
B_NN
protein_NN
complex_NN
in_IN
lupus_NN
T_NN
cells_NNS
._.

Freshly_RB
isolated_VBN
T_NN
cells_NNS
from_IN
lupus_NN
patients_NNS
,_,
rheumatoid_JJ
arthritis_NN
-LRB-_-LRB-
RA_NN
-RRB-_-RRB-
patients_NNS
,_,
and_CC
normal_JJ
individuals_NNS
were_VBD
activated_VBN
physiologically_RB
via_IN
the_DT
TCR_NN
with_IN
anti-CD3_NN
and_CC
anti-CD28_JJ
Abs_NNS
to_TO
assess_VB
proximal_JJ
membrane_NN
signaling_NN
,_,
and_CC
with_IN
PMA_NN
and_CC
a_DT
calcium_NN
ionophore_NN
-LRB-_-LRB-
A23187_NN
-RRB-_-RRB-
to_TO
bypass_VB
membrane-mediated_JJ
signaling_NN
events_NNS
._.

We_PRP
measured_VBD
the_DT
NF-kappa_NN
B_NN
binding_NN
activity_NN
in_IN
nuclear_JJ
extracts_NNS
by_IN
gel_NN
shift_NN
analysis_NN
._.

When_WRB
compared_VBN
with_IN
normal_JJ
cells_NNS
,_,
the_DT
activation_NN
of_IN
NF-kappa_NN
B_NN
activity_NN
in_IN
SLE_NN
patients_NNS
was_VBD
significantly_RB
decreased_VBN
in_IN
SLE_NN
,_,
but_CC
not_RB
in_IN
RA_NN
,_,
patients_NNS
._.

NF-kappa_NN
B_NN
binding_NN
activity_NN
was_VBD
absent_JJ
in_IN
several_JJ
SLE_NN
patients_NNS
who_WP
were_VBD
not_RB
receiving_VBG
any_DT
medication_NN
,_,
including_VBG
corticosteroids_NNS
._.

Also_RB
,_,
NF-kappa_NN
B_NN
activity_NN
remained_VBD
absent_JJ
in_IN
follow-up_JJ
studies_NNS
._.

In_IN
supershift_NN
experiments_NNS
using_VBG
specific_JJ
Abs_NNS
,_,
we_PRP
showed_VBD
that_IN
,_,
in_IN
the_DT
group_NN
of_IN
SLE_NN
patients_NNS
who_WP
displayed_VBD
undetectable_JJ
NF-kappa_NN
B_NN
activity_NN
,_,
p65_NN
complexes_NNS
were_VBD
not_RB
formed_VBN
._.

Finally_RB
,_,
immunoblot_NN
analysis_NN
of_IN
nuclear_JJ
extracts_NNS
showed_VBD
decreased_VBN
or_CC
absent_JJ
p65_NN
protein_NN
levels_NNS
._.

As_IN
p65_NN
complexes_NNS
are_VBP
transcriptionally_RB
active_JJ
in_IN
comparison_NN
to_TO
the_DT
p50_NN
homodimer_NN
,_,
this_DT
novel_JJ
finding_NN
may_MD
provide_VB
insight_NN
on_IN
the_DT
origin_NN
of_IN
abnormal_JJ
cytokine_NN
or_CC
other_JJ
gene_NN
transcription_NN
in_IN
SLE_NN
patients_NNS
._.

